AcelRx Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
AcelRx Pharmaceuticals, Inc. holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 21 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include NIYAD, ACELRX, DSUVIA, and ACELRX PHARMACEUTICALS, INC.. The owner is based in Redwood City, CA.
351 Galveston Drive
Redwood City, CA 94063
Showing of trademarks Trademarks
Trademark Classifications
AcelRx Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AcelRx Pharmaceuticals, Inc. have?
AcelRx Pharmaceuticals, Inc. has 23 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 14 abandoned, 4 cancelled.
What trademark classes does AcelRx Pharmaceuticals, Inc. file in?
AcelRx Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AcelRx Pharmaceuticals, Inc.'s most well-known trademarks?
AcelRx Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as NIYAD, ACELRX, DSUVIA, and ACELRX PHARMACEUTICALS, INC.. These are among 4 currently registered trademarks in the portfolio.
What is AcelRx Pharmaceuticals, Inc.'s trademark registration success rate?
AcelRx Pharmaceuticals, Inc. has a 18% trademark registration rate, with 4 out of 22 resolved applications resulting in successful registration. Currently, 1 application is pending review.